Eunice Kagucia/Lancet Infect Dis
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.Coldiron ME
Soumana I
Baudin E
Langendorf C
Mamiafo Tchoula C
Brah S
Karani A
Gallagher KE
Kagucia EW
Scott JAG
Grais RF
Lancet Infect Dis, (2025). 25:634-642
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.Bennett JC
Deloria Knoll M
Kagucia EW
Garcia Quesada M
Zeger SL
Hetrich MK
Yang Y
Herbert C
Ogyu A
Cohen AL
Yildirim I
Winje BA
von Gottberg A
Viriot D
van der Linden M
Valentiner-Branth P
Suga S
Steens A
Skoczynska A
Sinkovec Zorko N
Scott JA
Savulescu C
Savrasova L
Sanz JC
Russell F
Ricketson LJ
Puentes R
Nuorti JP
Mereckiene J
McMahon K
McGeer A
Mad'arova L
Mackenzie GA
MacDonald L
Lepp T
Ladhani SN
Kristinsson KG
Kozakova J
Klein NP
Jayasinghe S
Ho PL
Hilty M
Heyderman RS
Hasanuzzaman M
Hammitt LL
Guevara M
Grgic-Vitek M
Gierke R
Georgakopoulou T
Galloway Y
Diawara I
Desmet S
De Wals P
Dagan R
Colzani E
Cohen C
Ciruela P
Chuluunbat U
Chan G
Camilli R
Bruce MG
Brandileone MC
Bigogo G
Ampofo K
O'Brien KL
Feikin DR
Hayford K
Pserenade Team
Lancet Infect Dis, (2025). 25:457-470
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys.Gallagher KE
Adetifa IMO
Mburu C
Bottomley C
Akech D
Karani A
Pearce E
Wang Y
Kagucia EW
Goldblatt D
Hammitt LL
Scott JAG
Lancet Infect Dis, (2023). 23:1291-1301
